Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients


Por: Cuervo, G, Camoez, M, Shaw, E, Dominguez, MA, Gasch, O, Padilla, B, Pintado, V, Almirante, B, Molina, J, Lopez-Medrano, F, de Gopegui, ER, Martinez, JA, Bereciartua, E, Rodriguez-Lopez, F, Fernandez-Mazarrasa, C, Goenaga, MA, Benito, N, Rodriguez-Bano, J, Espejo, E, Pujol, M

Publicada: 30 oct 2015
Resumen:
Background: The aim of the study was to determine clinical and microbiological differences between patients with methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia (CRB) undergoing or not undergoing haemodialysis, and to compare outcomes. Methods: Prospective multicentre study conducted at 21 Spanish hospitals of patients with MRSA bacteraemia diagnosed between June 2008 and December 2009. Patients with MRSA-CRB were selected. Data of patients on haemodialysis (HD-CRB) and those not on haemodialysis (non-HD-CRB) were compared. Results: Among 579 episodes of MRSA bacteraemia, 218 (37.7 %) were CRB. Thirty-four (15.6 %) were HD-CRB and 184 (84.4 %) non-HD-CRB. All HD-CRB patients acquired the infection at dialysis centres, while in 85.3 % of the non-HD-CRB group the infection was nosocomial (p < .001). There were no differences in age, gender or severity of bacteraemia (Pitt score); comorbidities (Charlson score >= 4) were higher in the HD-CRB group than in the non-HD-CRB group (73.5 % vs. 46.2 %, p = .003). Although there were no differences in VAN-MIC >= 1.5 mg/L according to microdilution, using the E-test a higher rate of VAN-MIC >= 1.5 mg/L was observed in HD-CRB than in non-HD-CRB patients (63.3 % vs. 44.1 %, p = .051). Vancomycin was more frequently administered in the HD-CRB group than in the non-HD-CRB group (82.3 % vs. 42.4 %, p = <. 001) and therefore the appropriate empirical therapy was significantly higher in HD-CRB group (91.2 % vs. 73.9 %, p = .029). There were no differences with regard to catheter removal (79.4 % vs. 84.2 %, p = .555, respectively). No significant differences in mortality rate were observed between both groups (Overall mortality: 11.8 % vs. 27.2 %, p = .081, respectively), but there was a trend towards a higher recurrence rate in HD-CRB group (8.8 % vs. 2.2 %, p = .076). Conclusions: In our multicentre study, ambulatory patients in chronic haemodialysis represented a significant proportion of cases of MRSA catheter-related bacteraemia. Although haemodialysis patients with MRSA catheter-related bacteraemia had significantly more comorbidities and higher proportion of strains with reduced vancomycin susceptibility than non-haemodialysis patients, overall mortality between both groups was similar.

Filiaciones:
Cuervo, G:
 Hosp Univ Bellvitge, Dept Infect Dis, Barcelona 08907, Spain

Camoez, M:
 Bellvitge Hosp, Dept Microbiol, Barcelona, Spain

Shaw, E:
 Hosp Univ Bellvitge, Dept Infect Dis, Barcelona 08907, Spain

Dominguez, MA:
 Bellvitge Hosp, Dept Microbiol, Barcelona, Spain

Gasch, O:
 Hosp Parc Tauli, Dept Infect Dis, Sabadell, Spain

Padilla, B:
 Hosp Gen Gregorio Maranon, Dept Infect Dis, Madrid, Spain

Pintado, V:
 Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain

Almirante, B:
 Hosp Valle De Hebron, Dept Infect Dis, Barcelona, Spain

Molina, J:
 Hosp Virgen del Rocio, Dept Infect Dis, Seville, Spain

Lopez-Medrano, F:
 Hosp 12 Octubre, Dept Infect Dis, E-28041 Madrid, Spain

de Gopegui, ER:
 Hosp Son Espases, Dept Microbiol, Palma de Mallorca, Spain

Martinez, JA:
 Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain

Bereciartua, E:
 Hosp Cruces, Dept Infect Dis, Bilbao, Spain

Rodriguez-Lopez, F:
 Hosp Reina Sofia, Dept Infect Dis, Cordoba, Spain

Fernandez-Mazarrasa, C:
 Hosp Marques de Valdecilla, Dept Microbiol, Santander, Spain

Goenaga, MA:
 Hosp Donostia, Dept Infect Dis, Donostia San Sebastian, Spain

Benito, N:
 Hosp Santa Creu & Sant Pau, Dept Infect Dis, Barcelona, Spain

Rodriguez-Bano, J:
 Hosp Virgen Macarena, Dept Infect Dis, Seville, Spain

Espejo, E:
 Hosp Terrassa, Dept Infect Dis, Terrassa, Spain

Pujol, M:
 Hosp Univ Bellvitge, Dept Infect Dis, Barcelona 08907, Spain
ISSN: 14712334





BMC INFECTIOUS DISEASES
Editorial
BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 15 Número:
Páginas:
WOS Id: 000364278200001
ID de PubMed: 26518487
imagen Gold, Green Published

MÉTRICAS